Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center For Human Genetics And Laboratory Diagnostics, |
RCV002086740 | SCV002320757 | uncertain significance | Developmental and epileptic encephalopathy, 65 | 2022-01-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002086739 | SCV002389286 | likely benign | not provided | 2024-08-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002552345 | SCV003530753 | uncertain significance | Inborn genetic diseases | 2021-11-09 | criteria provided, single submitter | clinical testing | The c.3186C>G (p.I1062M) alteration is located in exon 28 (coding exon 27) of the CYFIP2 gene. This alteration results from a C to G substitution at nucleotide position 3186, causing the isoleucine (I) at amino acid position 1062 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |